Christian Joly is OMNIlife science, Inc.’s new vice president of Robotics and Navigation.
Joly New Robotic VP at OMNIlife

Joly joins the company after serving a stint as CEO of AdRoxx, a SaaS company focused on big data related to geotargeted information. Before AdRoxx, Joly was the chairman and CEO of Praxim, a medical device company that was acquired by OMNI’s parent company in June 2010. Before Praxim, Joly was the CEO of TAK Imaging, which was acquired by InSilica. Prior to TAK Imaging, he was senior vice president of marketing and business development at Intellon Corporation.
Before he joined Intellon, Joly headed the DVD and Imaging Business Units at LSI LOGIC. He holds an EDP in general management from the Kellogg School of General Management at Northwestern University and a B.S. in electrical engineering from the University of Rennes, France. In addition to his experience in leadership roles, he has been granted seven patents in the areas of VLSI (very large scale integration) design and imaging.
Joly said there is a significant need for innovation in the hip and knee surgical arena: “OMNI is on the cutting edge of work in this space.” He added that the advanced robotic plans at OMNIlife science are not only exciting but revolutionary.
He will report directly to OMNI’s President and CEO George Cipolletti.
OMNIlife
OMNIlife was founded in 1999 to design, manufacture and distribute orthopedic devices. The company is headquartered located in East Taunton, Massachusetts.
Just two month ago, the company closed on $27.5 million in debt financing. This past February, the company announced the successful completion of more than 3, 000 total knee replacements in the U.S. using OMNI’s surgical navigation system. The technology at the core of this system is the company’s APEX Robotic Technology.
APEX System
According to the company, APEX uses a robotic cutting guide that supports the surgeon’s ability to make more accurate bone cuts and optimize the position of the implant versus conventional surgical navigation techniques. The system utilizes a patented BoneMorphing technology to create a virtual 3D model of each patient’s unique anatomy without preoperative CT or MRI imaging, enabling precise positioning of the robotic cutting guide.
Most robotic technologies being used today for knee resurfacing procedures are only offered for unicompartmental or partial knee replacement, says the company. OMNI’s system is specifically designed for total knee replacement.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.